Condition: Pulmonary Fibrosis · Lung Fibrosis · Idiopathic Pulmonary Fibrosis · Sponsor: Erasme University Hospital
To evaluate the effect of an anti-fibrotic treatment initiation on the fibrotic activity as assessed by FAPI PET/CT.
This description comes directly from the study's public registry record.
Benjamin Bondue · + 32 (2) 555 5758 · benjamin.bondue@hubruxelles.be
Always discuss trial participation with your own doctor first.
| Medecine | Brussels, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06189820